Objective: To determine the nature of alternatively spliced isoforms of fibronectin expressed in healthy bovine articular cartilage and cartilage derived from human osteoporotic and osteoarthritic joints.
Introduction
Fibronectin (FN) is a 220 kDa extracellular matrix (ECM) glycoprotein encoded by a single gene and produced by many cell types. It is postulated to play an important role in numerous cellular activities including adhesion, proliferation, differentiation, cytoskeletal organization, wound healing and apoptosis 1, 2 . FN exists as a hetero-or homo-dimer cross-linked by disulfide bonds. Each FN monomer is composed of multiple repeats of three types of homologous units, designated I, II and III. A number of mRNA alternative splicing events occur at three sites, extra type III domain A (ED-A), extra type III domain B (ED-B) and the variable region (V) also known as the type III-connecting segment (III-CS). The ED-A and ED-B domains are encoded by single exons while the V domain in humans has been shown to contain two 5′-splice donor sites and three 3′-splice acceptor sites producing five potential isoforms [3] [4] [5] [6] .
The ECM of articular cartilage comprises predominantly type II collagen and the aggregating proteoglycan, aggrecan. It also contains a number of minor components, such as FN, which have both structural and signalling roles 7 . Several recent studies in the dog, horse and rabbit have examined the FN isoforms expressed in cartilage and demonstrated an unusual population distribution, including an isoform found exclusively in cartilage 8 . This isoform, designated (V+C) − accounts for 50-80% of FN transcripts in cartilage and lacks the V domain as well as the fifteenth type-III repeat (III-15) and the tenth type-I repeat (I-10) [7] [8] [9] . Recent studies have demonstrated that the (V+C) − isoform forms dimers only with other (V+C) − monomers 10 . The precise role of the (V+C) − isoform in the ECM of cartilage has not been elucidated. However, cartilage homeostasis is regulated in part by the interaction of chondrocytes with extracellular matrix components and FN is known to play a role in chondrocyte adhesion and mechano-transduction signalling events 11 , suggesting that alternatively spliced forms of fibronectin might have a regulatory role in these processes.
In this study we have examined FN splicing in bovine articular cartilage and have identified two novel alternatively spliced forms whose expression is dependent upon the presence of an extracellular matrix. We have extended this analysis to cartilage derived from human osteoarthritic and osteoporotic joints and show that these two novel splice forms are expressed in humans and appear to be cartilage-specific. In addition a third splice variant which encodes a truncated form of FN was identified in osteoarthritic cartilage. This data raises the possibility that these isoforms have specific roles in maintaining structural integrity or regulating 'outside-in' signaling in chondrocytes.
Materials and methods

EXPERIMENTAL SAMPLES
Bovine articular cartilage was obtained from the metacarpal-phalangeal joints of cows (aged 18-24 months) within 12 h of slaughter. Human hip femoral head cartilage (osteoporosis patients aged 56-71 years) and tibial plateau knee cartilage [osteoarthritis (OA) patients aged 54-76 years] was obtained within 8 h of the time of joint replacement. Tissue was collected under the approval of the local ethical committee.
CHONDROCYTE CULTURE
Chondrocytes were isolated by collagenase digestion as follows: 0.5 g of diced cartilage (3×3×1 mm) was incubated in 5 ml Dulbecco's Modified Eagles Medium (DMEM, Life Technologies) containing 10 mg/ml bacterial collagenase (Sigma), 25 mM HEPES, pH 7.5 for 2 h at 37°C with constant mixing before being filtered through a 70 m cell strainer. Chondrocytes were then recovered from the media by centrifugation and washed once in PBS before plating at a density of 1.5×10 3 cells per cm 2 . Cartilage explants were maintained in DMEM with 100 U/ml penicillin (Sigma) and 100 g/ml streptomycin (Sigma) with media changes every 2 days. Isolated chondrocytes and the human cell lines, HepG2 (hepatoma ATCC No. HB-8065) and SW1353 (chondrosarcoma ATCC No. HTB-94) were maintained as monolayers in DMEM with 10% (v/v) FCS (Gibco BRL), 100 U/ml penicillin and 100 g/ml streptomycin and passaged after reaching confluence.
RNA ISOLATION
Isolation of total RNA was carried out using RNAzol B reagent (Biogenesis Inc, U.S.A.). Bovine and human articular cartilage were diced (3×3×1 mm) and 0.5 g wet-weight immediately placed in 0.5 ml of RNAzol B. Monolayer cultures were extracted by direct application of RNAzol B (2 ml per 75 cm 2 ). Samples were then processed as described by the manufacturer. The quality of the RNA isolated from the OA derived chondrocytes was variable as assessed by agarose gel electrophoresis. The osteoporosis derived chondrocytes consistently yielded high quality RNA. The disparity is likely to be a consequence of the diseased state of the osteoarthritic cartilage.
RT-PCR, CLONING AND SEQUENCE ANALYSIS
For RT-PCR, first strand cDNA was synthesized from total RNA using Superscript II reverse transcriptase (Life Technologies). 1 g of RNA was reverse transcribed in a final volume of 20 l using random hexamer oligonucleotides as primers. Human multiple tissue cDNAs were obtained commercially (Clontech, U.S.A.). Oligonucleotide primer positions in the V region are indicated in Fig. 1 . The nucleotide sequences were as follows: VDF: 5′-TATG AAGTGAGTGTCTATGCTCT-3′; VDR: 5′-TTCTGCCACTG TTCTCC-3′ 8 ; FNIII-14F: 5′-GGGTCTCCTCCCAGAGA AGT-3′; FNI-10R: 5′-CGAGTCATCCGTAGGTTGGT-3′; FNIII-15F: 5′-TCCTGTTGGCACTGATGAAG-3′; FNI-11R: 5′-GCTCATCATCTGGCCATTTT-3′ and type II collagen T2F: 5′-GGAGATCCGGGCTGAGGGCAACA-3′ and T2R: 5′-GAATGGGCGTCAGGTCAGGTCAGC-3′. GAPDH primers were obtained from Stratagene. All transcripts were amplified from 1 l of first strand cDNA reaction using Expand DNA polymerase (Boehringer). PCR reactions contained 25 pmol of each primer, 0.2 mM dNTPs and 0.5 U Expand DNA polymerase in a final volume of 25 l, and were amplified for 35 cycles of 94°C for 30 s, 60°C for 30 s and 72°C for 60 s, followed by a final extension period of 72°C for 10 min. Reaction products were resolved in agarose gels alongside 1 kb DNA ladder (GibcoBRL), stained with ethidium bromide (10 g/ml) and visualized by UV transillumination. For cloning, amplified cDNA fragments were gel purified, using the QIAquick procedure (QIAGEN) and ligated into pCR2.1-TOPO (Invitrogen) following the manufacturer's instructions. Recombinant plasmids were transformed into TOP10 E. coli (Invitrogen), grown in L-Broth containing ampicillin (100 g/ml) and purified by anion-exchange chromatography following the manufacturer's instructions (QIAGEN). DNA sequence was Osteoarthritis and Cartilage Vol. 10, No. 7determined using an automated fluorescent-based system (Prizm ABI 377).
STATISTICAL ANALYSIS
The significance of the distibution of FN splice variants was determined using a two-tailed Fisher's exact test.
Results
SPLICING PATTERN OF FN IN BOVINE ARTICULAR CARTILAGE
To investigate alternative splice forms of FN (shown schematically in Fig. 1 ), RT-PCR was performed using VDF/VDR primer pairs with cDNA prepared from bovine metacarpal-phalangeal articular cartilage and the human cell lines, SW1353 (chondrosarcoma) and HepG2 (hepatoma). Based upon previously described splicing events this analysis was predicted to produce up to four V + products, a V − product and additionally, in cartilage, the cartilage-specific (V+C) − product 8 . Figure 2 shows that these products were successfully amplified with the expected distribution. In addition, in the cartilage sample there were two additional products intermediate in size between the V − and (V+C) − transcripts. These were cloned, sequenced and found to correspond to alternatively spliced transcripts which, if translated, would specifically delete the amino acid sequences of the variable region and either the fifteenth type III domain (III-15) or the tenth type I domain (I-10). We have designated these isoforms (V+III-15) − and (V+I-10) − respectively. The nucleotide sequences have been submitted to the EMBL/Genbank databases under accession numbers AJ320525 & AJ320526.
SPLICING PATTERN OF FN IN HUMAN ARTICULAR CARTILAGE
To determine whether the novel splice forms were also present in human tissue, RNA was derived from human hip femoral head cartilage obtained at the time of joint replacement surgery. RT-PCR analysis indicated splicing in the V domain [ Fig. 3(A) ]. The splice forms identified included the (V+I-10) − and (V+III-15) − isoforms as well as the previously described V+, V-, and (V+C) − isoforms. The (V+I-10)
− and (V+III-15) − PCR products were cloned and sequenced to confirm their identity. The nucleotide sequences have been submitted to the EMBL/Genbank databases under accession numbers AJ320528 & AJ320529.
The splicing profile of the V-region of FN in other human tissues was determined using RT-PCR [ Fig. 3(B) ]. The (V+III-15) − , (V+I-10) − and (V+C) − splice variants were not detected in heart, placenta, liver or lung.
SPLICING PATTERN IN HUMAN OSTEOPOROTIC AND OSTEOARTHRITIC CARTILAGE
To determine whether FN isoform expression was altered in disease we compared the expression profiles using RNA derived from seven human osteoporotic hip femoral head cartilage samples and ten human osteoarthritic knee tibial plateau cartilage samples. In order to Table I . The primer pair III-14F/I-10R enabled us to assess specific expression of the (V+III-15) − isoform as it could not amplify the (V+I-10) − isoform. The (V+III-15) − isoform was detected in one of the seven osteoporotic femoral head cartilage samples (sample 1, Table I ) and eight of the 10 osteoarthritic tibial plateau cartilage samples (Fig. 4 & Table I ). Using a two-tailed Fishers exact test expression of the (V+III-15) − isoform in osteoarthritic cartilage was shown to be statistically significant (P=0.015). The longer V + isoforms were successfully amplified in the osteoporotic samples but were not detected in the osteoarthritic samples. This is probably a consequence of the quality of the RNA obtained from the tissue reducing the synthesis of longer cDNA products.
The primer pair III-15F/I-11R enabled us to look at specific expression of the (V+I-10) − isoform. As shown in Fig. 5 and Table I this isoform was detected in all seven of the osteoporotic cartilage samples but was found only in three of the osteoarthritic samples. Using a two-tailed Fisher's exact test expression of the (V+I-10) − isoform in osteoporotic cartilage was shown to be statistically significant (P=0.01). An additional PCR product was detected in four of the osteoarthritic samples (Fig. 5) . This product was cloned, sequenced and shown to correspond to a FN isoform resulting from a splice event which removed 139 nucleotides from within the III-15 domain. Translation of this DNA sequence demonstrates that the result of the splicing event is the introduction of a frame shift resulting in the addition of four new amino acids in the III-15 domain before premature termination of the coding sequence. It is possible that additional 5′ splicing events associated with this isoform might correct for this frame shift but this would probably result in significant alteration of the upstream amino acid sequence. We have designated this splice variant III-15X and deposited it in the EMBL/Genbank databases under accession number AJ320527.
EXPRESSION OF NOVEL FN ISOFORMS IS MATRIX DEPENDENT
To examine whether these additional splice variants were expressed in a matrix dependent manner, as has been described for the (V+C) − isoform 9 , a single bovine metacarpal-phalangeal joint was used to establish cartilage explant cultures, and to isolate and seed chondrocytes in monolayer culture. RNA was isolated from these culture systems as well as directly from the original tissue. RT-PCR analysis was carried out as described in Materials and methods. Figure 6 indicates that the splicing profile after 14 days of explant culture was identical to that of cartilage extracted directly after removal from the joint. However, the chondrocyte monolayer culture showed a time dependent loss of the (V+C) − transcript and the novel (V+III-15) − and (V+I-10) − isoforms. This loss was associated with the decreased expression of type II collagen.
EXAMINATION OF GENOMIC DNA SEQUENCE OF THE HUMAN FN GENE
Examination of the described FN exon-intron organization shows that the novel (V+III-15) − , (V+I-10) − and III-15X isoforms are all generated by splicing events between 
The presence or absence of each FN splice variant was determined by RT-PCR. The statistical significance of the distribution was determined using a two-tailed Fisher's exact test . Fig. 6 . Expression of novel FN isoforms is dependent upon the presence of the extracellular matrix. Cartilage and chondrocytes were cultured as described, RNA extracted and RT-PCR carried out using primers specific for FN, Type II collagen and GAPDH. Lane 1-bovine articular cartilage from the metacarpal-phalangeal joint extracted on day 1, Lane 2-bovine articular cartilage extracted after explant culture for 14 days, Lane 3-primary bovine chondrocytes were isolated from the metacarpal-phalangeal joint and extracted after 7 days in monolayer culture, Lane 4-primary bovine chondrocytes isolated from the metacarpal-phalangeal joint and extracted after 14 days in monolayer culture, Lane 5-water control. Size markers (SM).
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Discussion
We have examined the mRNA splicing events in the variable region of the FN gene and have identified two novel cartilage specific isoforms of FN designated (V+III-15)
− and (V+I-10) − . Both variants are expressed in juvenile bovine articular cartilage and adult human articular cartilage. This is the first description of multiple splicing events in humans involving the sequences encoding the III-15 and I-10 domains.
It has been reported previously that the major FN isoform in equine and canine cartilage is (V+C) −8 . Our RT-PCR experiments confirm that this observation extends to human cartilage. The relative intensities of PCR products suggest that the novel (V+III-15) − and (V+I-10) − isoforms may be minor species, although it should be noted that RT-PCR is not a truly quantitative measure. We have examined the expression profiles of the FN splice forms in osteoporotic hip and osteoarthritic knee cartilage and established that in the 17 samples analysed expression of the (V+III-15) − isoform was significantly associated with osteoarthritic cartilage (P=0.015) while expression of the (V+I-10)
− isoform was associated with osteoporotic cartilage (P=0.01). Due to the nature of the clinical material obtained, the possibility remains that this distribution is related to location, hip vs knee, rather than disease. A third isoform designated III-15X was also identified only in the osteoarthritic samples. This isoform is the result of a splice event within the III-15 domain and in the absence of more 5′ splicing events results in a frame shift leading to the addition of four novel amino acids in the III-15 domain before premature termination of the coding sequence. Both the (V+III-15)
− and the (V+I-10) − isoforms are expressed in bovine juvenile cartilage, whereas in adult human cartilage expression appears to be differential. There may be distinct roles for each isoform in early developing cartilage vs mature adult tissue.
We have also confirmed that expression of the (V+C)-isoform is dependent upon the presence of an ECM and that this is also the case for the (V+III-15) − and (V+I-10)-isoforms 9 . When chondrocytes were isolated and cultured in the absence of a matrix, expression of the (V+III-15) − , (V+I-10) − and (V+C) − isoforms was lost within 7 days and this was coincident with the loss of expression of type II collagen. Thus, expression of these isoforms of FN appears to be associated with a chondrocytic phenotype and lost during the dedifferentiation observed when chondrocytes are placed in monolayer culture.
Alternative splicing of the V region was observed between all four described donor and acceptor splice sites when only the V region was subject to splicing. However, only the most 5′ and most 3′ sites were used in splicing events involving the III-15 and I-10 sequences. A recent study has shown that the splicing of the ED-B exon is regulated in part by purine-rich elements (PREs) which act as enhancer elements and are required for accurate 5′ splice site selection in the absence of a strong consensus sequence 12 . A separate study has also implicated TGCATG repeats in regulating ED-B splicing 13 . The critical sequence elements required to regulate 3′ splice site selection have not yet been identified; however, splicing suppressors have been described in the FN ED-A exon which rely on secondary structure for activity 14, 15 . In the cartilage specific splicing profiles we have described PREs are located immediately upstream of the majority of the splice sites. These sequences may be involved in regulating the choice of 5′ splice site selection through interaction with chondrocyte-specific splicing factors.
We have demonstrated the existence of mRNA species for the (V+III-15) − and (V+I-10) − variants. If these isoforms of FN are expressed then one can speculate on their functional significance. The III-15 and I-10 segments have been implicated in regulating the rate of matrix assembly, and loss of either of these domains would significantly impair the ability of fibronectin to incorporate into the cartilage ECM environment 16 . The III-15 domain may also be required for binding to chondroitin sulfate, the major glycosaminoglycan attached to aggrecan 17, 18 . Consequently selective deletion of the III-15 or I-10 domains may impact upon rate and type of matrix synthesized. Studies using deminectins, truncated FN constructs, have indicated that the (V+C) − isoform is secreted as a homodimer and is not capable of heterodimerization with V + isoforms 10 . Also, a mutant FN lacking the I-10 to I-12 region when expressed in COS cells is secreted with monomers exceeding dimers by two to one. It remains to be determined whether the (V+III-15) − and (V+I-10) − isoforms are expressed as proteins and would be able to heterodimerize with the (V+C) − isoform or favor monomeric secretion.
In addition FN is involved in 'outside-in' signaling events via interactions with several integrins and a number of other ECM molecules, for instance the RGD site in the tenth type III repeat has been shown to interact with the 5 1 and the v 1 integrins, while the V and III-14 domains are recognized by the 4 1 integrin 19 . All of these integrins are expressed by chondrocytes 20 . There are also many domains in FN which contain cryptic activities only realized by conformational change or proteolytic cleavage. Expression of the III-15X variant lacking sequences C-terminal to the III-15 domain would prevent dimerization and possibly expose a sequence within the III-14 domain that has been shown to have antiadhesive properties 21, 22 . Deletion of the V region in concert with either the III-15 or I-10 domains is likely to cause conformational changes in the surrounding domains and may impact upon the associated matrix interactions or signalling events. It may also alter the relative susceptibility to proteolytic cleavage. In OA elevated levels of FN and catabolic FN fragments are found in the cartilage and synovial fluid. Loss of the V, III-15 and/or I-10 domains may alter the type of fragments generated.
In conclusion, this study describes three additional splicing events that occur in the sequence encoding the V, III-15 and I-10 regions of FN. The (V+III-15)
− and (V+I-10) − isoforms appear to be cartilage-specific and their expression is dependent upon an extracellular matrix. The RT-PCR analysis, while not being truly quantitative, implies that the (V+III-15) − , (V+I-10) − and III-15X isoforms are minor splice variants in cartilage when compared with the predominant (V+C) − isoform. The physiological role of these variants in normal and diseased cartilage remains to be determined.
